Skip to content
healthcare.dev

BM BIO7

NDC 85816-3007, Calc phos, Ferr phos, Kali phos, Nat phos, Nat sulf., globule, from BM Private Limited.

Product NDC
85816-3007
Status
Listed
Labeler
BM Private Limited
Dosage form
GLOBULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/85816-3007 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SODIUM SULFATE3 [hp_X]/g
  • TRIBASIC CALCIUM PHOSPHATE3 [hp_X]/g
  • POTASSIUM PHOSPHATE, DIBASIC3 [hp_X]/g
  • FERROSOFERRIC PHOSPHATE3 [hp_X]/g
  • SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE3 [hp_X]/g

Pharmacologic classes

Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]

Package NDCNDC-11Package
85816-3007-18581630070125 g in 1 BOTTLE, GLASS (85816-3007-1)
85816-3007-285816300702500 g in 1 JAR (85816-3007-2)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 85816-3007 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/85816-3007 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 85816-3007. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.